# Bendamustine and tofacitinib treatment of T-cell prolymphocytic leukemia: a case report

**Authors:** 银芬 邓, 小丽 钱, 月 许, 筱 杨, 红建 袁

PMC · DOI: 10.3760/cma.j.cn121090-20231024-00227 · Chinese Journal of Hematology · 2024-04-01

## Full-text entities

- **Diseases:** T-cell prolymphocytic leukemia (MESH:D015461)
- **Chemicals:** tofacitinib (MESH:C479163), Bendamustine (MESH:D000069461)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11168006/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11168006/full.md

---
Source: https://tomesphere.com/paper/PMC11168006